{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:17:04Z","timestamp":1776089824287,"version":"3.50.1"},"reference-count":21,"publisher":"Pharmaceutical Society of Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2015]]},"DOI":"10.1248\/bpb.b14-00678","type":"journal-article","created":{"date-parts":[[2015,1,31]],"date-time":"2015-01-31T17:05:36Z","timestamp":1422723936000},"page":"285-291","source":"Crossref","is-referenced-by-count":9,"title":["Pharmacokinetics and Brain Distribution of Tetrahydropalmatine and Tetrahydroberberine after Oral Administration of DA-9701, a New Botanical Gastroprokinetic Agent, in Rats"],"prefix":"10.1248","volume":"38","author":[{"given":"Ji Won","family":"Jung","sequence":"first","affiliation":[{"name":"College of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences, The Catholic University of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Sam","family":"Kwon","sequence":"additional","affiliation":[{"name":"Research Center, Dong-A Pharmaceutical Co."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Seok","family":"Jeong","sequence":"additional","affiliation":[{"name":"Research Center, Dong-A Pharmaceutical Co."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwon","family":"Son","sequence":"additional","affiliation":[{"name":"Research Center, Dong-A Pharmaceutical Co."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Eun","family":"Kang","sequence":"additional","affiliation":[{"name":"College of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences, The Catholic University of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Lee TH, Choi JJ, Kim DH, Choi S, Lee KR, Son M, Jin M. Gastroprokinetic effects of DA-9701, a new prokinetic agent formulated with <i>Pharbitis semen<\/i> and <i>Corydalis tuber<\/i>. <i>Phytomedicine<\/i>, <b>15<\/b>, 836\u2013843 (2008).","DOI":"10.1016\/j.phymed.2008.02.019"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Kim ER, Min BH, Lee SO, Lee TH, Son M, Rhee PL. Effects of DA-9701, a novel prokinetic agent, on gastric accommodation in conscious dogs. <i>J. Gastroenterol. Hepatol.<\/i>, <b>27<\/b>, 766\u2013772 (2012).","DOI":"10.1111\/j.1440-1746.2011.06924.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Jung YS, Kim MY, Lee HS, Park SL, Lee KJ. Effect of DA-9701, a novel prokinetic agent, on stress-induced delayed gastric emptying and hormonal changes in rats. <i>Neurogastroenterol. Motil.<\/i>, <b>25<\/b>, 254\u2013259, e166 (2013).","DOI":"10.1111\/nmo.12053"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Choi S, Choi JJ, Jun JY, Koh JW, Kim SH, Kim DH, Pyo MY, Choi S, Son JP, Lee I, Son M, Jin M. Induction of pacemaker currents by DA-9701, a prokinetic agent, in interstitial cells of Cajal from murine small intestine. <i>Mol. Cells<\/i>, <b>27<\/b>, 307\u2013312 (2009).","DOI":"10.1007\/s10059-009-0039-6"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Kwon YS, Son M. DA-9701: A new multi-acting drug for the treatment of functional dyspepsia. <i>Biomol. Ther.<\/i> (Seoul), <b>21<\/b>, 181\u2013189 (2013).","DOI":"10.4062\/biomolther.2012.096"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Jung JW, Kim JM, Jeong JS, Son M, Lee HS, Lee MG, Kang HE. Pharmacokinetics of chlorogenic acid and corydaline in DA-9701, a new botanical gastroprokinetic agent, in rats. <i>Xenobiotica<\/i>, <b>44<\/b>, 635\u2013643 (2014).","DOI":"10.3109\/00498254.2013.874610"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Barichella M, Cereda E, Pezzoli G. Major nutritional issues in the management of Parkinson\u2019s disease. <i>Mov. Disord.<\/i>, <b>24<\/b>, 1881\u20131892 (2009).","DOI":"10.1002\/mds.22705"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Shindler JS, Finnerty GT, Towlson K, Dolan AL, Davies CL, Parkes JD. Domperidone and levodopa in Parkinson\u2019s disease. <i>Br. J. Clin. Pharmacol.<\/i>, <b>18<\/b>, 959\u2013962 (1984).","DOI":"10.1111\/j.1365-2125.1984.tb02571.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Laduron PM, Leysen JE. Domperidone, a specific <i>in vitro<\/i> dopamine antagonist, devoid of <i>in vivo<\/i> central dopaminergic activity. <i>Biochem. Pharmacol.<\/i>, <b>28<\/b>, 2161\u20132165 (1979).","DOI":"10.1016\/0006-2952(79)90198-9"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Kim JM, Yoon JN, Jung JW, Choi HD, Shin YJ, Han CK, Lee HS, Kang HE. Pharmacokinetics of hederacoside C, an active ingredient in AG NPP709, in rats. <i>Xenobiotica<\/i>, <b>43<\/b>, 985\u2013992 (2013).","DOI":"10.3109\/00498254.2013.788231"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Chiou WL. Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level\u2013time curve. <i>J. Pharmacokinet. Biopharm.<\/i>, <b>6<\/b>, 539\u2013546 (1978).","DOI":"10.1007\/BF01062108"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Gao Y, Hu S, Zhang M, Li L, Lin Y. Simultaneous determination of four alkaloids in mice plasma and brain by LC-MS\/MS for pharmacokinetic studies after administration of <i>Corydalis rhizoma<\/i> and <i>Yuanhu zhitong<\/i> extracts. <i>J. Pharm. Biomed. Anal.<\/i>, <b>92<\/b>, 6\u201312 (2014).","DOI":"10.1016\/j.jpba.2013.12.037"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Zhang Y, Shi K, Wen J, Fan G, Chai Y, Hong Z. Chiral HPLC determination and stereoselective pharmacokinetics of tetrahydroberberine enantiomers in rats. <i>Chirality<\/i>, <b>24<\/b>, 239\u2013244 (2012).","DOI":"10.1002\/chir.21988"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Zuo F, Nakamura N, Akao T, Hattori M. Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography\/ion trap mass spectrometry. <i>Drug Metab. Dispos.<\/i>, <b>34<\/b>, 2064\u20132072 (2006).","DOI":"10.1124\/dmd.106.011361"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Hong Z, Wen J, Zhang Q, Fan G, Chai Y, Wu Y. Study on the stereoselective excretion of tetrahydropalmatine enantiomers in rats and identification of <i>in vivo<\/i> metabolites by liquid chromatography-tandem mass spectrometry. <i>Chirality<\/i>, <b>22<\/b>, 355\u2013360 (2010).","DOI":"10.1002\/chir.20750"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Zhao M, Li LP, Sun DL, Sun SY, Huang SD, Zeng S, Jiang HD. Stereoselective metabolism of tetrahydropalmatine enantiomers in rat liver microsomes. <i>Chirality<\/i>, <b>24<\/b>, 368\u2013373 (2012).","DOI":"10.1002\/chir.22020"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Wu C, Yan R, Zhang R, Bai F, Yang Y, Wu Z, Wu A. Comparative pharmacokinetics and bioavailability of four alkaloids in different formulations from <i>Corydalis decumbens<\/i>. <i>J. Ethnopharmacol.<\/i>, <b>149<\/b>, 55\u201361 (2013).","DOI":"10.1016\/j.jep.2013.05.043"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Hong Z, Fan G, Le J, Chai Y, Yin X, Wu Y. Brain pharmacokinetics and tissue distribution of tetrahydropalmatine enantiomers in rats after oral administration of the racemate. <i>Biopharm. Drug Dispos.<\/i>, <b>27<\/b>, 111\u2013117 (2006).","DOI":"10.1002\/bdd.489"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Chueh FY, Hsieh MT, Chen CF, Lin MT. DL-Tetrahydropalmatine-produced hypotension and bradycardia in rats through the inhibition of central nervous dopaminergic mechanisms. <i>Pharmacology<\/i>, <b>51<\/b>, 237\u2013244 (1995).","DOI":"10.1159\/000139365"},{"key":"20","unstructured":"20) Huang KX, Jin GZ. The antagonistic effects of tetrahydroprotoberberines on dopamine receptors: electrophysiological studies. <i>Sci. China B<\/i>, <b>35<\/b>, 688\u2013696 (1992)."},{"key":"21","unstructured":"21) U.S. FDA. \u201cGuidance for Industry: estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. U.S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research, Pharmacology and Toxicology, July 2005.\u201d: \u2039http:\/\/www.fda.gov\/downloads\/Drugs\/Guidance\/UCM078932.pdf\u203a, cited 23 September, 2014."}],"container-title":["Biological &amp; Pharmaceutical Bulletin","Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/38\/2\/38_b14-00678\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T07:42:07Z","timestamp":1566286927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/38\/2\/38_b14-00678\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b14-00678","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}